These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 3121971

  • 1. Increase in norepinephrine turnover after tyrosine or DL-threo-3,4-dihydroxyphenylserine (DL-threo-DOPS).
    Gibson CJ.
    Life Sci; 1988; 42(1):95-102. PubMed ID: 3121971
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The effects of L-threo-dihydroxyphenylserine on norepinephrine metabolism in rat brain.
    Semba J, Takahashi R.
    Psychiatry Res; 1985 Aug; 15(4):319-26. PubMed ID: 3934694
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of DL-erythro-dihydroxyphenylserine on the locomotor activity of the mouse.
    Mori T, Nakajima T, Hashimoto H, Noto T, Kato N.
    Pharmacol Biochem Behav; 1985 Jun; 22(6):979-83. PubMed ID: 2862644
    [Abstract] [Full Text] [Related]

  • 8. Differential effects of DSP-4 administration on regional brain norepinephrine turnover in rats.
    Logue MP, Growdon JH, Coviella IL, Wurtman RJ.
    Life Sci; 1985 Aug 05; 37(5):403-9. PubMed ID: 4021721
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Reversal of the reserpine-induced ptosis by L-threo-3,4-dihydroxy-phenylserine (L-threo-DOPS), a (-)-norepinephrine precursor, and its potentiation by imipramine or nialamide.
    Kato T, Katsuyama M, Karai N, Hirose A, Nakamura M, Katsube J.
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Mar 05; 332(3):243-6. PubMed ID: 3086752
    [Abstract] [Full Text] [Related]

  • 11. Improvement in freezing phenomenon of Parkinson's disease after DL-threo-3, 4-dihydroxyphenylserine.
    Ogawa N, Kuroda H, Yamamoto M, Nukina I, Ota Z.
    Acta Med Okayama; 1984 Jun 05; 38(3):301-4. PubMed ID: 6431755
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. DL-Threo-3,4-dihydroxyphenylserine does not exert a pressor effect in orthostatic hypotension.
    Hoeldtke RD, Cilmi KM, Mattis-Graves K.
    Clin Pharmacol Ther; 1984 Sep 05; 36(3):302-6. PubMed ID: 6432398
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Beneficial attenuating effect of L-threo-3,4-dihydroxyphenylserine on postural hypotension in anesthetized rats.
    Satoh S, Oyabe A, Tanno M, Suzuki-Kusaba M.
    Arzneimittelforschung; 1989 Sep 05; 39(9):1123-9. PubMed ID: 2511849
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Diuretic effects of L-threo-3,4-dihydroxyphenylserine (L-threo-DOPS) in anesthetized rats.
    Morimoto S, Matsumura Y, Ohyama T, Shinyama H, Ichihara T, Takahashi Y, Hisaki K.
    Jpn J Pharmacol; 1990 Mar 05; 52(3):431-9. PubMed ID: 2110272
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.